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Context: There is variability in the congenital hypothyroidism (CH) newborn screening TSH cutoff
across the United Kingdom.
Objective: To determine the influences of year, gender, and ethnicity on screening variability and
examine whether there is an optimal operational TSH cutoff.
Design and Setting: Single center, retrospective population study using blood spot TSH cards
received by the Great Ormond Street Hospital Screening Laboratory between 2006 and 2012.
Patients: A total of 824 588 newborn screening blood spot TSH cards.
Intervention: Blood spot TSH results were recorded with demographic data including the Ethnic
Category Code.
Main OutcomeMeasures: The proportions of samples exceeding different TSH cutoffs, ranked by
ethnicity.
Results: The proportion of samples exceeding the TSH cutoff increased over time, with the cutoff
at 4mU/L, butnot at 6mU/L. Therewas a consistent trendwithethnicity, irrespectiveof cutoff,with
the odds ratio of exceeding the TSH cutoff lowest (1.0) in White babies, higher in Pakistani and
Bangladeshi (2.0), and highest in Chinese (3.5).
Conclusions:Theblood spot TSH screeningdatademonstrate a clear rankingaccording toethnicity
for differences in mean TSH. This suggests that there may be ethnic differences in thyroid physi-
ology. Ethnic diversity within populations needs to be considered when establishing and inter-
preting screening TSH cutoffs. (J Clin Endocrinol Metab 101: 3445–3449, 2016)
TheUKnewbornblood spot screeningprogram for con-genital hypothyroidism (CH) was established in
1983 (1). It has led to the diagnosis and early levothyrox-
ine treatment for thousands of babies with CHwhomight
otherwise have developed profound neurodevelopmental
impairment.
TheUK screening program for CH is based on themea-
surement of TSH concentration in a heel-prick blood spot
taken at 5–10 days of age. Babies whose TSH concentra-
tion exceeds 20 mU/L are considered to be screen positive
and require immediate referral for venous thyroid func-
tion tests and clinical evaluation. A lower borderline TSH
cutoff was introduced to minimize false-positive notifica-
tions due to a delayed physiological TSH surge. It was
assumed that such babies would normalize TSH over the
following week. Therefore, in babies with an initial blood
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spot screen between the lower cutoff and 19.9 mU/L, a
second sample is taken 7 days after the first. Cases that
remain abnormal are referred for venous testing and clin-
ical evaluation (1).
The value of this lower TSH cutoff has been the subject
of much debate because differences have arisen over time
between screening laboratories across the United King-
dom and internationally (2–4). This has occurred in re-
sponse to differences and changes in TSH assays, reports
ofmissed casesofCH,and the rigorwithwhich thenormal
reference values were constructed (5). The lower cutoff in
our center is currently 6 mU/L.
There is a lack of evidence to assess the optimal lower
cutoff point in terms of screening sensitivity and specific-
ity. In addition,UKchildren vary between regions in terms
of ethnicity and iodine sufficiency, which may also influ-
ence the optimal cutoff value.
Toaddress these issues,we examined screeningdata for
thewhole newborn population froma single laboratory in
North London over a 7-year period. We aimed to docu-
ment changes in TSH concentration over time and the
differences between ethnic groups.
Subjects and Methods
Between January 2006 and December 2012, 824 588 babies
from the North Thames region (which includes Greater London
and parts of the counties of Bedfordshire, Essex, and Hertford-
shire)were screened forCHat theGreatOrmondStreetHospital
(GOSH) Newborn Blood Spot Screening Laboratory.
The biochemical results were recorded along with demo-
graphic data, including gestational age. Ethnicity was coded us-
ing the Ethnic Category Code published by the Health & Social
Care Information Centre (6). Percentages by ethnic group were
compared with the London and overall UK populations using
data from the 2011 UK census (7).
Assays
Blood spot TSH concentrations were measured by the auto-
mated dissociation enhanced lanthanide fluoroimmunoassay
(AutoDELFIA) (Perkin Elmer) system. The method is calibrated
using six standards with values ranging from  1 mU/L to 300
mU/L, with some variation for each kit lot. The interbatch pre-
cision of thismethod ranges from6 to8%,with no trendover the
range of values. TSH in dried blood spot specimens has been
shown to be stable for at least 1 month at room temperature. If
stored at 4°C with desiccant, there is no degradation of TSH for
at least 1 year. All samples in this study were analyzed within 1
month of sample collection. There was no modification or
change to the assay procedure during the study period, and no
assay drift was reported. The assay was enrolled in the UK Ex-
ternal Quality Assurance Scheme, and reports were satisfactory
throughout this period.
Statistics
The blood spot TSH data were tabulated by ethnic group,
year, sex, and integer TSH value. Binomial models were then
fitted to the counts usingweighted logistic regression, to estimate
the effects of ethnicity, year, and sex on the chance of TSH ex-
ceeding a prespecified cutoff point, for integer cutoffs between 4
and 10 mU/L.
The ethnic group-specific odds ratios of the TSH exceeding
each cutoff, adjusted for year and sex, were then plotted to show
how the ranking of ethnic groups varied by cutoff point, with
White British babies as the reference.
The 2 test was used to compare the frequency of ethnic
groups in the various population groups. Trends for the number
screened per annum were assessed using Pearson’s correlation
coefficient.
Results
A total of 824 588 newborn babies from North Thames
were screened for CH at GOSH between January 2006
and December 2012 (Table 1). The numbers rose signif-
icantly over time (r 0.93; P .002) with an extra 1700
babies per year. Overall, there were 47% girls, 49%boys,
and 4% sex not recorded. The UK screening program as-
sumespotential immaturityof the thyroidaxis in infants
32weeks old, and a second card is requested 4weeks later
in thosewith a normal TSH result. Fewer than 1.4%of the
cohort were recorded to have a gestational age  32  6
weeks, and the ethnic distribution within this group was
similar to the cohort as a whole.
The percentages of babies with blood spot TSH con-
centrations exceeding specific cutoffs are shown in Table
2. Adjusted for ethnicity and sex, the proportion of sam-
ples exceeding a cutoff point of 4 mU/L on the first card
rose significantly over time (P  .0001), but with cutoffs
of 6, 8, or 10mU/L therewas no such trend (P .1). Thus,
theproportionof samplesbetween4and6mU/L increased
over time, but over 6 mU/L it was stable (Figure 1). Con-
versely, adjusted for ethnicity and year, there was no dif-
ference between males and females in the proportion ex-
ceeding cutoffs 4, 6, or 8 mU/L, but there was a small
female excess for 10 mU/L (P  .0003).
Table 3 shows the percentages by ethnic group in the
GOSHscreening samples and subsequent referrals in2011
compared to the 2011 UK census (7). The census showed
Table 1. Numbers of First Newborn Blood Spot Screening Cards by Year
Year 2006 2007 2008 2009 2010 2011 2012
Card no. 110174 115882 117341 118758 119870 120449 122114
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a significantly different ethnic distribution in London
compared to the United Kingdom (P  .01). The ethnic
distribution of blood spot samples received by the GOSH
Laboratory was similar to London 2011, apart from a
slight excess of “Other”. Compared to the laboratory-
screened group, therewas an excess of Asian/Asian British
patients referred to GOSH for further evaluation and
treatment (n  138) (P  .01).
Figure 2 indicates the ethnic breakdown in 17 catego-
ries including “not stated.” The histogram shows the
group sample sizes, covering an 80-fold range fromWhite
British (n306 708) toWhite Irish (n3760).Theethnic
groups were ranked by the proportion exceeding a TSH
cutoff point of 6 mU/L (the screening cutoff used by
GOSH), adjusted for year and sex, andFigure2also shows
the odds ratio of exceeding the 6 mU/L cutoff in each
ethnic group compared to White British babies, ranked
from low to high (green points). Similar results, distin-
guished by color and point size, are shown for cutoff
points of 4, 8, and 10 mU/L. As the cutoff point rises, the
screen-in prevalence falls, reflected by the points for the
higher cutoffs becomingprogressively smaller indiameter.
The graph shows a consistent trend, irrespective of cutoff
value, with a low group (predominantly White) near 1, a
middle group (Indian, African, andCaribbean) above 1.5,
and a high group (Pakistani, Bangladeshi, and Chinese)
exceeding 2. Note that all of the Chinese odds ratios ex-
ceed 3.5.
Discussion
Newborn screening TSH cutoff points differ between cen-
ters nationally and internationally. There is no clear con-
sensus on the rationale for the cutoff points, which are
based on historical opinion, differences in biochemical as-
says, and missed cases of CH. The UK 2011 population
census data showed differences in the ethnic distribution
in London compared to the United Kingdom as a whole.
TheGOSH screening laboratory ethnicity data reflect this
London distribution, and the diversity has provided an
opportunity to examine the effect of ethnicity on the TSH
cutoff point.
WeexaminedTSHcutoffs at integer values from4 to10
mU/L.For cutoffs of6and8mU/L, therewasno trendover
time andno gender difference, so in this sense these cutoffs
are optimal. Figure 2 demonstrates that the odds ratios of
TSH exceeding the cutoff vary highly significantly by eth-
nicity. For the lowest cutoff point (4mU/L, red points), the
odds ratios are relatively close to 1 (the White British ref-
erence), but as the cutoff point rises, they move progres-
sively away from it. This suggests that the ethnic differ-
ences are due to a shift in mean TSH, so the further one
goes into the tail of the distribution, themore pronounced
the ethnic differences are. These results imply that there
are ethnic differences in thyroid physiology,whichmay be
due to genetic factors and which should be considered
when examining TSH cutoffs in different populations.
Table 2. Overall Percentages of TSH Exceeding
Various Cutoff Points
Cutoff
Point
4
mU/L
5
mU/L
6
mU/L
8
mU/L
10
mU/L
% Exceeding
cutoff point
1.06 0.49 0.30 0.16 0.10
Figure 1. Distribution of blood spot TSH concentrations for the years 2006–2012.
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Consanguinity is not recorded on the newborn screening
cards, but this would be relevant if there were genetic
differences.
The ethnic groups with the greatest shifts in mean TSH
concentration originate from regions of the world with
historical records of iodine deficiency (8). There is increas-
ing evidence that the UK population of young women is
iodine insufficient (9–11), which may compound this ef-
fect. Previous attempts to link newborn screening TSH
data to iodine have had mixed results. The World Health
Organization (WHO) previously suggested that a popu-
lation frequency of  3% with a TSH  5 mU/L at 3–4
days of age was indicative of iodine sufficiency in a pop-
ulation (12). The introduction of iodinated salt in Poland
reduced the prevalence of neonatal TSH  5 mU/L from
20 to 5%over 5 years (13).However, theWHOdefinition
is controversial, with limitations based on the day of sam-
pling and the assay sensitivity (14).
There is a need to examine iodine sufficiency of UK
newborns in more detail. Our data showed only 1% ex-
ceeding a TSH cutoff point of 4mU/L, although screening
occurs later at 5–10 days. Babies with raised TSH con-
centrations secondary to iodine insufficiency have a pre-
ventable cause of CH. This has neurodevelopmental im-
plications (10) and, although the hypothyroidism may be
transient if the baby is subsequently given iodine-fortified
milk formula, there remains a group who may have
chronic iodine insufficiency, mild CH, and an ongoing
need for T4 therapy.
It is unlikely that ethnic differences can be explained by
differences in the postnatal TSH surge. In this dataset,
screening takes place at 5–10 days of age. Babies with a
borderline result of 6–19.9mU/L have a second screening
card taken 7 days after the first and are referred if it is
 6 mU/L. It is assumed that this second card would have
normalized in those babies with a delayed TSH surge. We
didnot lookat secondcarddata, but the increase in clinical
referrals for Asian babies implies that this ethnic effect
persists and reflects an alternative physiological effect (2).
This newborn screening dataset demonstrates a yearly
increase in babies screened, reflecting the rising birth rate
in this geographical area. The study has various strengths.
The population used is large and unselected, and hence is
representative of normal newborns. The effects of illness
and prematurity are small in this population. The age of
the population is well defined between 5 and 10 days of
postnatal life, and specimen collection and processingwas
standardized. Analysis was undertaken in a single labo-
ratory using the same assay methodology. Assay perfor-
mance did not change significantly over time. Finally, the
sample size was sufficient to detect differences between
ethnic groups. The population mix in the London area
differs from other regions of the United Kingdom (Table
3), and our data demonstrate that the ethnicity of babies
born within the GOSH screening catchment is represen-
tative of the London population.
Table 3. Percentages by Ethnic Group in the Great Ormond Street Hospital Screening and Referral for Treatment
Populations Compared to UK and London 2011 Census Figures
Ethnic Group
UK 2011
Census
London 2011
Census
GOSH Laboratory
2011
GOSH Referrals
2011 (n  138)
White 86 60 53 44
Asian/Asian British 7.5 18 19 34
Black/Black British/African/Caribbean 3.3 13 10 9.2
Mixed 2.2 5.0 6.0 2.8
Other 1.0 3.4 12 7.8
Data are expressed as percentages.
Figure 2. Odds ratio of exceeding a blood spot screening cutoff with
the British White population set at 1.0. The sample size in each ethnic
group is shown by the block histogram. Ethnic code categories are
represented by letters according to Office for National Statistics
classification (7).
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As stated above, the best cutoff to use would be either
6 or 8mU/L, although this conclusion is based on year and
gender differences rather than screening sensitivity and
specificity. Screening sensitivity and specificity for CH are
based on long-term neurodevelopmental outcomes in the
untreated/late-treated child, and data exist only for his-
torical cases of severe CH. However, this large dataset
from a single center based in an ethnically diverse city
provides new insights into the effects of ethnicity on
screening TSH concentrations, and this needs to be con-
sidered when setting cutoff points. It also suggests that
subtle variation in thyroid physiology and/or iodine suf-
ficiency may account for differences in the reported inci-
dence of CH and in particular for the increase in “milder”
forms of dyshormonogenesis.
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